Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.30
-0.09 (-1.07%)
Mar 6, 2026, 8:56 AM EST - Market open
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $474.17 million as of March 6, 2026. Its market cap has increased by 280.05% in one year.
Market Cap
474.17M
Enterprise Value
313.20M
1-Year Change
280.05%
Ranking
Category
Stock Price
$8.30
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $474.17M, a decrease of -47.20%. That is a compound annual growth rate of -26.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 479.32M | -10.74% |
| Dec 31, 2025 | 537.02M | 232.60% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prothena Corporation | 530.79M |
| Lexeo Therapeutics | 528.43M |
| ADC Therapeutics | 525.24M |
| Rocket Pharmaceuticals | 523.30M |
| Neumora Therapeutics | 518.31M |
| Tectonic Therapeutic | 514.67M |
| Lyell Immunopharma | 505.61M |
| Zevra Therapeutics | 502.74M |